HRTX compared with ADMA: revenue, margins and what each company keeps, and the suppliers and customers both name

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

ADMAAdma Biologics, Inc.

Mkt capRevenueRevenue

Compare

HRTXHeron Therapeutics, Inc.

ADMAAdma Biologics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

HRTXHeron Therapeutics, Inc.

0.28▼−4.61%· post 0.28· delayed

Mkt cap$56.0MRevenue$38MQ2 FY26Revenue$155MFY25

ADMAAdma Biologics, Inc.

11.12▲+0.54%· post 11.12· delayed

After hoursNov 3 '26delayed

Mkt cap$2.5BRevenue$124MQ2 FY26Revenue$510MFY25

Compare

After hoursNov 3 '26delayed

HRTXHeron Therapeutics, Inc.

ADMAAdma Biologics, Inc.

0.28▼−4.61%post 0.28delayed

Price

11.12▲+0.54%post 11.12delayed

$56.0M

Mkt cap

$2.5B

Q2 FY26$38M

Revenue

$124MQ2 FY26

FY25$155M

Revenue

$510MFY25

HRTX0.28▼−4.61%vsADMA11.12▲+0.54%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

HRTX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only HRTX 0

None

Shared 0

No disclosed counterparties: HRTX.

Only ADMA 7

GRFSGrifols Worldwide Operationssupplier

—KEDPlasmaunlistedsupplier

—Areth, LLC ("Areth")unlistedsupplier

—Priority Healthcare Distributionunlistedcustomer

3 more · ADMA chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

HRTX, solidADMA, dashed